Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis

Bodil Petersen, Klaus Bendtzen, Nils Koch-Henriksen, Mads Ravnborg, Christian Ross, Per Soelberg Sorensen, Danish Multiple Sclerosis Group

    41 Citations (Scopus)

    Abstract

    The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.
    Original languageEnglish
    JournalMultiple Sclerosis
    Volume12
    Issue number3
    Pages (from-to)247-52
    Number of pages6
    ISSN1352-4585
    Publication statusPublished - 1 Jun 2006

    Fingerprint

    Dive into the research topics of 'Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.

    Cite this